Expression of Ki-67 and p27Kip1 in fine-needle aspirates from breast carcinoma and benign breast diseases

Diagnostic Cytopathology

Volumn 39, Issue 5, 2011, Pages 333-340

  Ramljak, Vesna ^a   Sučić, Mirna ^b,c   Vrdoljak, Danko Velemir ^a   Borojević, Nikola ^d  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d Zabok General Hospital   (Croatia)

Author keywords

breast carcinoma; breast cell atypia; fibroadenoma; Ki 67; p27

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; BREAST DISEASE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTODIAGNOSIS; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; CARCINOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79954527064     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21391     Document Type: Article

References (38)

1. Choi YD, Choi YH, Lee JH, Nam JH, Juhng SW, Choi C,. Analysis of fine needle aspiration cytology of the breast: A review of 1297 cases and correlation with histological diagnoses. Acta Cytol 2004; 48: 801-806. (Pubitemid 39518259)
2. Simsir A, Rapkiewicz A, Cangiarella J,. Current utilization of breast FNA in a cytology practice. Diagn Cytopathol 2009; 37: 140-142.
3. Lieu D,. Value of cytopathologist-performed ultrasound-guided fine-needle aspiration as a screening test for ultrasound-guided core-needle biopsy in nonpalpable breast masses. Diagn Cytopath 2009; 37: 262-269.
4. Kocjan G,. Needle aspiration cytology of the breast: Current perspective on the role in diagnosis and management. Acta Med Croatica 2008; 62: 391-401.
5. Veronesi U,., Goldhirsch A, Costa A, Zurrida S,. New technologies for diagnosis and treatment of breast cancer: meeting highlights from the Fourth Milan Breast Cancer Conference (Milan. June 5-7, 2002). Breast 2003; 12: 223-225.
6. Layfield LJ, Dodd LG,. Cytologically low grade malignancies: An important interpretative pitfall responsible for false negative diagnoses in fine-needle aspiration of the breast. Diagn Cytopath 1996; 15: 250-255.
7. Rogers LA, Lee KR,. Breast carcinoma simulating fibroadenoma or fibrocystic change by fine-needle aspiration. Am J Clin Pathol 1992; 98: 155-160.
8. Marković-Glamočak M, Boban D, Sučić M, Oberman B, Åćukanec-Åpoljar M,. 1992. Significance of proliferative epithelial changes in breast fine-needle aspiration. Cancer 1992; 70: 781-783.
9. Deb RA, Matthews P, Elston CW, Ellis IO, Pinder SE,. An audit of "equivocal" (C3) and "suspicious" (C4) categories in fine needle aspiration cytology of the breast. Cytopathology 2001; 12: 219-226. (Pubitemid 32695177)
10. Ahmed HG, Ali AS, Almobarak AO,. Utility of fine-needle aspiration as a diagnostic technique in breast lumps. Diagn Cytopathol 2009; 37: 881-884.
11. Day C, Moatamed N, Fimbres AM, Salami N, Lim S, Apple SK,. A retrospective study of the diagnostic accuracy of fine-needle aspiration for breast lesions and implications for future use. Diagn Cytopathol 2008; 36: 855-860.
12. Ishikawa T, Hamaguchi Y, Tanabe M, et al. False-positive and false-negative cases of fine-needle aspiration cytology for palpable breast lesions. Breast Cancer 2007; 14: 388-392.
13. Nguansangiam S, Jesdapatarakul S, Tangjitgamol S,. Accuracy of fine needle aspiration cytology from breast masses in Thailand. Asian Pac J Cancer Prev 2009; 10: 623-626.
14. Kalogeraki A, Kafousi M, Ieromonachou P, et al. Telomerase activity as a marker of invasive ductal breast carcinomas on FNABs and relationship to other prognostic variables. Anticancer Res 2005; 25: 1927-1930. (Pubitemid 40904587)
15. Sučić M, Boban D, Marković-Glamočak M, et al. Expression of cyclooxigenase-2 in fine needle aspirates from breast carcinoma and benign breast diseases. Breast 2003; 12: 51-57. (Pubitemid 36395486)
16. Krop IE, Sgroi D, Porter DA, et al. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci USA 2001; 98: 9796-9801. (Pubitemid 32769383)
17. Zhan L, Rosenberg A, Bergami KC, et al. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 2008; 135: 865-878.
18. De Paola F, Vecci AM, Granato AM, et al. p27/kip1 expression in normal epithelium, benign and neoplastic breast lesions. J Pathol 2002; 196: 26-31.
19. Zagouri F, Sergentanis TN, Zografos GC,. Precursors and preinvasive lesions of the breast: The role of molecular prognostic markers in the diagnostic and therapeutic dilemma. World J Surg Oncol 2007; 5: 57-67.
20. Leong ASY, Sormunen RT, Vinyuvant S, Hamdani RW, Suthipintawong C,. Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma: A comparison of eight contemporary grading systems. Am J Clin Pathol 2001; 115: 709-718. (Pubitemid 33051538)
21. Barbareschi M, van Tinteren H, Mauri FA, et al. p27(kip 1) expression in breast carcinomas: An immunohistochemical study on 512 patients with long-term follow-up. Int J Cancer 2000; 89: 236-241. (Pubitemid 30430739)
22. Gonzalez-Vela MC, Garijo MF, Fernandez F, Val-Bernal JF,. MIB1 proliferation index in breast infiltrating carcinoma: Comparison with other proliferative markers and association with new biological prognostic factors. Histol Histopathol 2001; 16: 399-406. (Pubitemid 32297637)
23. Starborg M, Gell K, Brundell E,. The murine Ki-67 cell proliferation antigen accumulates in the nucleolar and heterochromatic regions of interphase cells and at the periphery of the mitotic chromosomes in a process essential for cell cycle progression. J Cell Sci 1996; 109: 143-153.
24. Wong SC, Chan JK, Lee KC, Hsiao WL,. Differential expression of p16/p21/p27 and cyclin D1/D3 and their relationship to cell proliferation, apoptosis, and tumor progression in invasive ductal carcinoma of the breast. J Pathol 2001; 194: 35-42.
25. Kip1 expression and grading of breast cancer diagnosed on cytological samples. Diagn Cytopathol 2004; 30: 375-380. (Pubitemid 38788677)
26. von Minckwitz G, Sinn HP, Raab G, et al. Clinical response after two cycles compared to HER2. Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. Breast Cancer Res 2008; 10: R30.
27. Haji BE, Das DK, Al-Ayadhy B, et al. Fine-needle aspiration cytologic features of four special types of breast cancers: Mucinous, medullary, apocrine, and papillary. Diagn Cytopathol 2007; 35: 408-416. (Pubitemid 47021012)
28. Simsir A, Waisman J, Cangiarella J,. Fibroadenomas with atypia: Causes of under- and overdiagnosis by aspiration biopsy. Diagn Cytopathol 2001; 25: 278-284. (Pubitemid 33041800)
29. Robles-Frías A, González-Cámpora R, Martínez-Parra D, et al. Robinson cytologic grading of invasive ductal breast carcinoma: Correlation with histologic grading and regional lymph node metastasis. Acta Cytol 2005; 49: 149-153. (Pubitemid 40388106)
30. Khan QJ, Kilmer BF, O'Dea AP, Sales CM, Sharma P, Fabians CJ,. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer. Breast Cancer Res 2007; 9: R35.
31. Noel JC, Fernandez-Aguilar S, Buxant F, Boutemy R,. Proliferating activity in columnar cell lesions of the breast. Virchows Arch 2006; 449: 617-621. (Pubitemid 44832631)
32. Rego MF, Navarrete MA, Facina G, Falzoni R, Silva R, Baracat EC, Nazario AC,. Analysis of human mammary fibroadenoma by Ki-67 index in the follicular and luteal phases of menstrual cycle. Cell Prolif 2009; 42: 241-247.
33. Leonardo E, Volante M, Barbareschi M, et al. Cell membrane reactivity of MIB-1 antibody to Ki-67 in human tumors: Fact or artifact? Appl Immunohistochem Mol Morphol 2007; 15: 220-223. (Pubitemid 46828233)
34. Shaaban AM, Sloane JP, West CR, Foster CS,. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression. Am J Pathol 2002; 160: 597-604. (Pubitemid 34160337)
35. Zhou CJ, Zhang QH, Zhang TG, et al. Expression of ER. Ki-67 and cyclin D1 in the pre-cancerous breast of Chinese patients. Pathol Oncol Res 2009; 15: 153-158.
36. Nambiar M, Kari V, Raghavan SC,. Chromosomal translocations in cancer. Biochim Biophys Acta 2008; 1786: 139-152.
37. Pandey A, Singh AK, Maurya SK, et al. Genomic profiling of breast cancer. J Surg Oncol 2009; 99: 386-392.
38. Spataro VJ, Litman H, Viale G, et al. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V. Cancer 2003; 97: 1591-1600. (Pubitemid 36350701)